P2.01-07 Open-Label, Biomarker-Directed Platform Study in...

Journal of Thoracic Oncology 2019 / 10 Vol. 14; Iss. 10

P2.01-07 Open-Label, Biomarker-Directed Platform Study in NSCLC Patients Who Progressed on an Anti-PD-(L)1-Containing Therapy (HUDSON)

Lao-Sirieix, S., Heymach, J., Forde, P., Thomas, M., Park, K., Besse, B., Awad, M., Goss, G., Rizvi, N., Ambrose, H., Hanekom, W., Fox, S., Jewsbury, P., Pouliot, G., Mortimer, P., Patel, S., Sachsenm
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2019.08.1351
Date:
October, 2019
File:
PDF, 305 KB
2019
Conversion to is in progress
Conversion to is failed